Fig. 2
Expression and roles of ANXA2 in NB clinical samples. a. A general observation of ANXA2 expression in TMA of 42 NB samples. b, c. Five grades (0–4) of IHC staining of ANXA2 expression and proportion in NB samples (n = 42). d. ANXA2 expression is related to INSS stage of NB patients. e. ANXA2 expression is related to chemotherapy courses in NB patients. f. Kaplan-Meier survival analysis combined with Wald test of NB patients. A high level of ANXA2 was associated with poor prognosis (n = 24); a low level of ANXA2 was correlated with a longer survival time (n = 18; P = 0.008)